首页> 外文期刊>Annals of Clinical Biochemistry >Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories
【24h】

Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories

机译:JDS Lot 2血红蛋白A1c的日本标准参考材料。 I:日本糖尿病学会分配的值与日本和美国国内标准化计划以及国际临床化学联合会参考实验室获得的值的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society (JDS) previously recommended use of the primary calibrator (JDS Lot 1) prepared by the former Committee for Standardization of Glycohemoglobin for standardizing the measurement of haemoglobin A1c (HbA1c). Owing to the depletion of vials of Lot 1 in March 2001, the present committee certified a new reference material, Lot 2, now distributed by the Health Care Technology Foundation (HECTEF). The standardization programme for HbA1c measurement in Japan is currently based on Lot 2, which has values assigned from within Lot 1; the Lot 1 values were consensus values based on assays by laboratories in the Japanese national quality control programme. In this study, for the purpose of international comparison and standardization, Lot 2 was assayed by the JDS reference laboratories, the National Glycoprotein Standardization Program (NGSP) in the USA, and by reference laboratories approved by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). nnMethod: The HbA1c values of JDS Lot 2 were transferred from those assigned to Lot 1 using KO500, a high-resolution HPLC method, at three laboratories approved by the JDS committee. Subsequently, vials of JDS Lot 2 were shipped to and assayed by the NGSP in the USA and 10 IFCC reference laboratories. nnResult: The JDS-assigned HbA1c values (from Lot 1) are 4.04 for Level 1, 5.38 for Level 2, 7.32 for Level 3, 9.88 for Level 4, and 12.63 for Level 5, all expressed as a percentage of total haemoglobin. The values obtained by NGSP and the IFCC laboratories gave the following formulas: NGSP value (%) = JDS value (%) + 0.3%; IFCC value (%) = 1.068 x JDS value (%) -1.741%. nnConclusion: Although the values obtained by the IFCC laboratories are significantly lower than the values assigned to Lot 2 by the JDS, the relationship is linear. In addition, standardization of HbA1c based on JDS Lot 2 is currently at a satisfactory level in Japan. As a result, the reassignment of values for Lot 2 to agree with the IFCC values should be relatively easy and will be done after all relevant parties agree to the change.
机译:背景:日本糖尿病学会(JDS)糖尿病相关实验室测试标准化委员会以前建议使用由原糖化血红蛋白标准化委员会制备的一级校准品(JDS Lot 1)来标准化血红蛋白A1c( HbA1c)。由于2001年3月第一批小瓶的消耗,本委员会认证了新的参考材料第二批,现在由卫生保健技术基金会(HECTEF)分发。日本目前的HbA1c测量标准化程序基于Lot 2,其值在Lot 1内分配。批次1的值是基于日本国家质量控制计划中实验室测定的共识值。在本研究中,出于国际比较和标准化的目的,JDS参考实验室,美国国家糖蛋白标准化计划(NGSP)和国际临床化学与实验室医学联合会批准的参考实验室对Lot 2进行了测定。 (IFCC)。 nn方法:在JDS委员会批准的三个实验室中,使用高分辨率HPLC方法KO500将JDS批次2的HbA1c值从分配给批次1的HbA1c值转移。随后,将JDS批次2的小瓶运送到美国的NGSP和10个IFCC参考实验室进行分析。 nn结果:JDS分配的HbA1c值(来自批次1)对于级别1为4.04,对于级别2为5.38,对于级别3为7.32,对于级别4为9.88,对于级别5为12.63,均表示为总血红蛋白的百分比。 NGSP和IFCC实验室获得的值具有以下公式:NGSP值(%)= JDS值(%)+ 0.3%; IFCC值(%)= 1.068 x JDS值(%)-1.741%。 nn结论:尽管IFCC实验室获得的值明显低于JDS分配给批次2的值,但该关系是线性的。另外,基于JDS Lot 2的HbA1c标准化在日本目前处于令人满意的水平。因此,重新分配Lot 2的值以与IFCC值相一致应该相对容易,并且在所有相关方面都同意更改后才能完成。

著录项

  • 来源
    《Annals of Clinical Biochemistry》 |2005年第1期|p.41-46|共6页
  • 作者单位

    Department of Laboratory Medicine, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan and Chairman of the Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of Japan Diabetes Society;

    Department of Laboratory Medicine, Ehime University School of Medicine, Japan;

    Department of Laboratory Medicine, Toho University School of Medicine, Japan;

    Institute of Clinical Medicine, University of Tsukuba, Japan;

    Department of Laboratory Medicine, Keio University School of Medicine, Japan;

    Clinical Laboratory, Tokyo University Hospital, Japan;

    Institute of Biopathological Medicine, Japan;

    Health Care Technology Foundation Standard Reference Center, Japan;

    Clinical Research Institute, Kyoto National Hospital, Japan;

    Department of Clinical Laboratory Medicine, Wakayama Medical University, Japan;

    Department of Laboratory Medicine, University of Tokushima School of Medicine, Japan;

    Department of Laboratory Medicine, Kagawa University School of Medicine, Japan;

    Department of Laboratory Medicine, Fukuoka University School of Medicine, Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号